SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-110263
Filing Date
2021-04-08
Accepted
2021-04-08 16:29:04
Documents
13
Period of Report
2021-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d137831d8k.htm   iXBRL 8-K 30471
2 EX-4.1 d137831dex41.htm EX-4.1 603639
  Complete submission text file 0001193125-21-110263.txt   879858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvta-20210408.xsd EX-101.SCH 3065
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20210408_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20210408_pre.xml EX-101.PRE 10949
6 EXTRACTED XBRL INSTANCE DOCUMENT d137831d8k_htm.xml XML 3273
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 21815196
SIC: 8071 Services-Medical Laboratories